Herbal formula NRICM102 tested as pneumonia Add-On treatment
NCT ID NCT07583992
First seen May 25, 2026
Summary
This Phase 2 trial tests whether NRICM102, a Traditional Chinese Medicine, can help adults with community-acquired pneumonia reach clinical stability faster when added to standard antibiotic therapy. About 150 hospitalized participants will take either NRICM102 or a placebo for 7 days, alongside usual care. Researchers will monitor symptoms, vital signs, and safety to see if the herbal treatment offers any added benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMMUNITY ACQUIRED PNEUMONIA (CAP) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Research Institute of Chinese Medicine, Ministry of Health and Welfare
Taipei, 11221, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NRICM102 (a Traditional Chinese Medicine concentrated granule)
What this could lead to
If it works, this could provide an additional treatment option for community-acquired pneumonia, potentially speeding recovery and reducing hospital stays.
What could go wrong
This is a Phase 2 trial with only 150 participants, so results are preliminary. The herbal formula may not show significant benefit over placebo, and side effects are still being studied.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.